Within the TME, the release of IFN-γ and stimulation of oncogenic drivers could provoke PD-L1 overexpression on tumor cells through inhibiting PI3K-AKT and Ras-Raf-MEK-ERK mediated pathways (37). This evidence concerns the gene CD274 and neoplasm.